
About Spinol
Spinol is a Healthcare company founded in 2018 by Roey Shafrir. It develops innovative implants to seal disc ruptures after spinal surgery procedures. It operates on a B2B model. Its chief executive is Roey Shafrir. Spinol offers products and services including Octa Seal. Its focus areas include Medical Devices, Orthopedics, Spinal Implants and Surgical Solutions. Its competitors include Barricaid; 1 of its 1 listed competitors has raised funding.
Company details
Spinolmedical focuses on creating medical devices like Octa Seal, a superplastic biomaterial implant that seals disc ruptures post-discectomy to minimize reherniation and improve surgical outcomes. The device is made from FDA-approved Nitinol and designed for quick implantation during micro-discectomy. Based in Israel, the company collaborates with a multidisciplinary team of clinical advisors from various countries. It aims to address issues in spinal surgery by promoting natural spine movement and reducing the need for secondary procedures, targeting healthcare professionals globally.
- Founders Roey Shafrir
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website spinolmedical.com
Products & Services of Spinol
Spinol offers a comprehensive portfolio of products and services, including Octa Seal.
Implant seals disc ruptures after discectomy to reduce reherniation and pain.
People of Spinol
1 people are tracked at Spinol (1 in leadership).
| Name | Role | Group |
|---|---|---|
Roey Shafrir | Founder, CEO | Leadership |
Complete people profiles for Spinol
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Spinol
Spinol has 1 listed competitor in our database, 1 of them funded. They include Barricaid, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| barricaid.com | 2006 | Woburn, United States | $197.12M | 49 | Annular closure implants are provided for lumbar disc herniation treatment. |
Detailed competitors of Spinol
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
10 companies that operate in the same segment as Spinol (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | 4,125 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608.25 M | – | 197 | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Spinol
Spinol was founded in 2018.
Roey Shafrir is the current CEO of Spinol. They have also founded this company.
Spinolmedical focuses on creating medical devices like Octa Seal, a superplastic biomaterial implant that seals disc ruptures post-discectomy to minimize reherniation and improve surgical outcomes. The device is made from FDA-approved Nitinol and designed for quick implantation during micro-discectomy. Based in Israel, the company collaborates with a multidisciplinary team of clinical advisors from various countries. It aims to address issues in spinal surgery by promoting natural spine movement and reducing the need for secondary procedures, targeting healthcare professionals globally.
Spinol's top competitors include Barricaid.
Spinol offers Octa Seal.